Pure Global

Comparison of Non-pharmaceutical Treatments for Evaporative Dry Eye - Trial NCT05923528

Access comprehensive clinical trial information for NCT05923528 through Pure Global AI's free database. This phase not specified trial is sponsored by He Eye Hospital and is currently Not yet recruiting. The study focuses on Dry Eye. Target enrollment is 116 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05923528
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT05923528
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Comparison of Non-pharmaceutical Treatments for Evaporative Dry Eye
Comparison of Non-pharmaceutical Treatments for Evaporative Dry Eye: A Randomized Controlled Study

Study Focus

Dry Eye

IPL

Interventional

device

Sponsor & Location

He Eye Hospital

Timeline & Enrollment

N/A

Jul 01, 2023

Dec 31, 2023

116 participants

Primary Outcome

Non-invasive tear breakup time (NITBUT)

Summary

The lipid layer of the tear film is critical to maintaining the integrity of the tear film
 and deficiency in the tear film lipid layer (TFLL) is the cause of evaporative dry eye (EDE)
 in approximately 80% of dry eye disease patients, resulting in excessive evaporation
 (so-called hyperevaporative dry eye). This study protocol was designed to assess and compare
 the effects of intense pulsed light (IPL), heated eye mask (HEM), vectored thermal pulsation
 system (VTPS), and eyelid massage device (EMD) for improving signs and symptoms of EDE.
 
 EDE patients will be randomly divided into IPL, HEM, VTPS, and EMD groups and will be
 followed up for four weeks. The primary outcome measure will be non-invasive tear breakup
 time (NITBUT). The secondary outcome measures will include, tear film lipid layer score
 (TFLL), meibomian gland function and secretion quality change from baseline conjunctival and
 cornea staining (CFS) with fluorescein and lissamine, tear meniscus height (TMH),
 conjunctival hyperemia (RS score) and ocular surface disease index (OSDI) questionnaire.
 Additionally, adverse events also were monitored and documented.

ICD-10 Classifications

Ocular pain
Avulsion of eye
Other corneal deformities
Corneal ulcer
Dry mouth, unspecified

Data Source

ClinicalTrials.gov

NCT05923528

Device Trial